Assessment of gastrointestinal tolerability and efficacy of enteric-coated mycophenolate sodium (Myfortic) in heart transplant recipients.
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2010
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Heart transplant rejection
- Focus Adverse reactions
- 19 Jul 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 19 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2009 Planned end date changed from 1 Jan 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.